Changing the role of pCR in breast cancer treatment - an unjustifiable interpretation of a good prognostic factor as a “factor for a good prognosis“

Pathologic complete response (pCR) after neoadjuvant systemic therapy (NAST) of early breast cancer (EBC) has been recognized as a good prognostic factor in the treatment of breast cancer because of its significant correlation with long-term disease outcome. Based on this correlation, pCR has been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanovic, Nebojsa, Bjelica, Dragana, Loboda, Barbara, Bogdanovski, Masan, Colakovic, Natasa, Petricevic, Simona, Gojgic, Milan, Zecic, Ognjen, Zecic, Katarina, Zdravkovic, Darko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391828/
https://www.ncbi.nlm.nih.gov/pubmed/37534241
http://dx.doi.org/10.3389/fonc.2023.1207948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391828/
https://www.ncbi.nlm.nih.gov/pubmed/37534241
http://dx.doi.org/10.3389/fonc.2023.1207948

Ejemplares similares